Pluripotent Stem Cell Mass Production via Segmented Culture
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for mass-producing high-quality pluripotent stem cell stocks, particularly clinical iPS cells, face challenges due to low survival and adhesion rates, making it difficult to scale up production using suspension culture techniques effectively.
Innovation Solution
A method involving initial adherent culture followed by suspension culture, with specific conditions such as controlled carbon dioxide and lactic acid concentrations, and the use of ROCK inhibitors, to enhance cell growth and quality, allowing for the production of high-quality pluripotent stem cell stocks suitable for therapeutic use.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If suspension culture is used for mass production of pluripotent stem cells, then productivity is improved, but cell quality (survival and adhesion rates) deteriorates
Solution Approach 1:
The culture process is divided into two distinct stages: an initial adherent culture stage to establish high-quality cell colonies, followed by a suspension culture stage for mass expansion. This segmentation allows each stage to be optimized independently - adherent culture ensures quality while suspension culture enables scalability.
Solution Approach 2:
High-quality adherent cell colonies are established as a preliminary step before transitioning to suspension culture. This preliminary action creates a robust cell foundation that maintains quality characteristics while enabling subsequent large-scale production through suspension culture techniques.
2Reliability
If adherent culture is used to ensure high cell quality, then cell quality is improved, but productivity deteriorates due to large culture area requirements
Solution Approach 1:
The production process is segmented into quality-assurance phase (adherent culture) and mass-production phase (suspension culture). This allows the system to leverage the high quality output of adherent culture while avoiding its scalability limitations through the subsequent suspension culture stage.
Solution Approach 2:
The method transitions from two-dimensional adherent culture on solid surfaces to three-dimensional suspension culture in liquid media. This dimensional transition enables mass production while maintaining cell quality, as suspension culture does not require large surface areas for scaling.
3Productivity
If repeated passaging is performed to increase cell number, then productivity is improved, but cell quality deteriorates
Solution Approach 1:
The passage process is segmented into an initial adherent culture phase with limited passaging to establish quality, followed by suspension culture phase where cells are maintained through controlled passaging. This segmentation allows quality maintenance while achieving high cell numbers through the suspension phase.
Solution Approach 2:
The method changes critical culture parameters between stages - transitioning from adherent to suspension culture mode, adjusting passage timing and frequency, and modifying culture conditions to maintain quality characteristics throughout the expansion process.
Data Source
AI summary
The purpose of the present invention is to produce a large amount of a high-quality pluripotent stem cell stock. A mass production method of a pluripotent stem cell stock that comprises thawing starting cells followed by adhesion culture to thereby stabilize the cell conditions, and then growing the cells to a cell count that enables suspension culture. Subsequently, the cells are suspension cultured while precisely controlling the culture environment to thereby grow a large number of high-quality cells. Then, a stock is prepared at a low temperature from the cells having been grown by the suspension culture.